-
1دورية أكاديمية
المؤلفون: Bolaman, Z., Köseoglu, M., Ayyildiz, O., Kadiköylü, G., Sönmez, H.M., Demir, S., Müftuüoglu, E.
مصطلحات موضوعية: liver dysfunction, Chronic myelogenous leukemia, lung toxicity, male, mucosa inflammation, nausea and vomiting, Philadelphia 1 chromosome, pneumonia, prognosis, rash, Streptococcus infection, survival time, validation process, Adult, Antineoplastic Combined Chemotherapy Protocols, Blast Crisis, leukopenia, Blastic phase, High dose methylprednisolone, 5 aza 2' deoxycytidine, alpha interferon, azacitidine, carboplatin, cladribine, cytarabine, etoposide, fludarabine, granulocyte colony stimulating factor, hydroxyurea, imatinib
العلاقة: Haematologia; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.1163/156855902760262763Test; https://hdl.handle.net/11499/5346Test; 32; 49; 57; 2-s2.0-0036901814; WOS:000177405200007
-
2
المؤلفون: Aravantinos, Gerasimos, Bafaloukos, Dimitrios, Fountzilas, George, Christodoulou, C., Papadimitriou, C., Pavlidis, Nicholas, Kalofonos, H. P., Gogas, H., Kosmidis, Paraskevas A., Dimopoulos, M. A.
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalofonos, H. P. [0000-0002-3286-778X]
المصدر: Annals of Oncology
مصطلحات موضوعية: medicine.medical_treatment, Docetaxel, Skin disease, Gastroenterology, Carboplatin, Granulocyte colony-stimulating factor, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Prospective Studies, Treatment outcome, Drug safety, Etoposide, Ovarian Neoplasms, Multicenter study, Clinical trial, Oxaliplatin, Local, Oncology, Vertigo, Disease Progression, Taxoids, Infection, Human, Diarrhea, Neoplasm recurrence, medicine.medical_specialty, Bone marrow suppression, Paclitaxel, Clinical article, Febrile neutropenia, Antineoplastic Agents, Methylprednisolone, Article, Disease-Free Survival, Ovarian cancer, Humans, Platinum-resistant, Cancer recurrence, Aged, Disease progression, Drug infusion, Recombinant granulocyte colony stimulating factor, Follow up, Myalgia, Leukopenia, Monotherapy, medicine.disease, Cancer combination chemotherapy, Drug effect, Regimen, Drug resistance, Cisplatin, Ovarian neoplasms, Controlled clinical trial, Nausea and vomiting, Phytogenic, Middle aged, Fatigue, Priority journal, Platinum derivative, Anemia, Vinorelbine, Hematology, Middle Aged, Arthralgia, Ondansetron, Anorexia, Treatment Outcome, Drug choice, Female, medicine.symptom, medicine.drug, Adult, Abdominal pain, Neutropenia, Ovary cancer, Disease-free survival, Navelbine, Vinblastine, Mucosa inflammation, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Chemotherapy, Phase 2 clinical trial, Stomatitis, business.industry, Alopecia, Taxane derivative, Gemcitabine, Thrombocytopenia, Antineoplastic Agents, Phytogenic, Cancer survival, Surgery, Drug efficacy, Doxorubicin, Drug Resistance, Neoplasm, Neoplasm, Neoplasm Recurrence, Local, Antiemetic agent, Topotecan, business, Controlled study, Constipation, Prospective studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e836ea784e7dd1d62801cbb6bcc90bTest
https://doi.org/10.1093/annonc/mdg292Test -
3دورية أكاديمية
المؤلفون: Bourhis, Jean, Sire, Christian, Graff, Pierre, Grégoire, Vincent, Maingon, Philippe, Calais, Gilles, Gery, Bernard, Martin, Laurent, Alfonsi, Marc, Desprez, Patrick, Pignon, Thierry, Bardet, Etienne, Rives, Michel, Geoffrois, Lionel, Daly-Schveitzer, Nicolas, Sen, Sok, Tuchais, Claude, Dupuis, Olivier, Guerif, Stéphane, Lapeyre, Michel, Favrel, Véronique, Hamoir, Marc, Lusinchi, Antoine, Temam, Stéphane, Pinna, Antonella, Tao, Yun Gan, Blanchard, Pierre, Aupérin, Anne
المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service de radiothérapie oncologique, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Centre de malformations vasculaires congénitales
المصدر: The Lancet Oncology, Vol. 13, no. 2, p. 145-153 (2012)
مصطلحات موضوعية: Carboplatin, Cancer combination chemotherapy, Cancer control, Cancer radiotherapy, Cancer staging, Chemoradiotherapy, Controlled study, Dose response, Female, Follow up, Head and neck carcinoma, Fluorouracil, Human, Hypopharynx carcinoma, Larynx carcinoma, Major clinical study, Male, Monotherapy, Mouth carcinoma, Mucosa inflammation, Mucosal disease, Multiple cycle treatment, Acceleration, Open study, Oropharynx carcinoma, Patient compliance, Phase 3 clinical trial, Priority journal, Progression free survival, Radiation dose
العلاقة: boreal:124330; http://hdl.handle.net/2078.1/124330Test; info:pmid/22261362; urn:ISSN:1470-2045; urn:EISSN:1474-5488
الإتاحة: https://doi.org/10.1016/S1470-2045Test(11)70346-1
http://hdl.handle.net/2078.1/124330Test -
4دورية أكاديمية
المساهمون: Pavlidis, Nicholas 0000-0002-2195-9961, Pentheroudakis, George 0000-0002-6632-2462, Boussios, Stergios 0000-0002-2512-6131
المصدر: Annals of Gastroenterology
مصطلحات موضوعية: Antineoplastic agent, Cisplatin, Cytarabine, Dacarbazine, Doxorubicin, Fluorouracil, Human, Methotrexate, Patient care, Procarbazine, Carboplatin, Chemotherapy, Abdominal pain, Anorexia, Bone marrow suppression, Constipation, Diarrhea, Drug efficacy, Mucosa inflammation, Nausea and vomiting, Ondansetron, Oxaliplatin, Stomatitis, Taxane derivative, Review, Erlotinib, Imatinib, Unindexed drug, Gastrointestinal symptom, Incidence
-
5
المؤلفون: Karabulut, Bülent, Özdemir, Feyyaz, Tunalı, Didem
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Veterinerlik Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Kurt, Ender, Çubukçu, Erdem, Ölmez, Ömer Fatih, Kurt, Meral, Avcı, Nilüfer, Evrensel, Türkkan, Manavoǧlu, Osman, AAJ-1027-2021, AAA-3961-2020
مصطلحات موضوعية: Male, Turkey, Systemic treatment, Docetaxel, Carboplatin, Multiple cycle treatment, Elderly, Overall survival, Treatment outcome, Disease course, Drug safety, Survival time, Drug tolerability, Anemia, Anorexia, Oxaliplatin, Retrospective study, Oncology, Female, Taxoids, Fluorouracil, Age factors, Human, Neutropenia, Paclitaxel, Disease-free survival, Stomach cancer, Clinical article, Stomach neoplasms, Drug response, Adenocarcinoma, Article, Mucosa inflammation, Antineoplastic combined chemotherapy protocols, Advanced cancer, Humans, Ramucirumab, Rivoceranib, Line, Aged, Stomatitis, 1st-line chemotherapy, Time factors, Post treatment survival, Phase-II trial, Kaplan-meier estimate, Thrombocytopenia, RAndomized-trial, Cancer survival, Cancer combination chemotherapy, Retrospective studies, Older, Drug efficacy, Geriatric patient, Progression free survival, Cisplatin, Gastric cancer
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______9458::cd36031629b181314823467479cfa5b7Test
http://hdl.handle.net/11452/32810Test -
6دورية أكاديمية
المؤلفون: Lazaridis, G., Pentheroudakis, George, Pavlidis, Nicholas
المساهمون: Pavlidis, Nicholas 0000-0002-2195-9961, Pentheroudakis, George 0000-0002-6632-2462
المصدر: Critical reviews in oncology/hematology
مصطلحات موضوعية: Female, Antineoplastic agents, Cyclophosphamide, Doxorubicin, Human, Humans, Breast neoplasms, Carboplatin, Paclitaxel, Alopecia, Anemia, Antineoplastic combined chemotherapy protocols, Arthralgia, Constipation, Drug efficacy, Drug safety, Fatigue, Febrile neutropenia, Infection, Leukopenia, Mucosa inflammation, Navelbine, Neutropenia, Stomatitis, Thrombocytopenia, Cardiotoxicity, Disease free survival, Review, Docetaxel, Overall survival
الإتاحة: https://doi.org/10.1016/j.critrevonc.2007.07.002Test
https://gnosis.library.ucy.ac.cy/handle/7/42119Test -
7دورية أكاديمية
المؤلفون: Danson, S., Middleton, M. R., O'Byrne, Kenneth J., Clemons, M., Ranson, M., Hassan, J., Anderson, H., Burt, P. A., Fairve-Finn, C., Stout, R., Dowd, I., Ashcroft, L., Beresford, C., Thatcher, N.
المصدر: Cancer
مصطلحات موضوعية: Carboplatin, Chemotherapy, Gemcitabine, Nonsmall cell lung carcinoma (NSCLC), cisplatin, dexamethasone, ifosfamide, metoclopramide, mitomycin, ondansetron, paclitaxel, vinblastine, adult, advanced cancer, aged, alopecia, article, blood toxicity, cancer survival, clinical trial, controlled clinical trial, controlled study, disease course, edema, flu like syndrome, hearing impairment, human, lung non small cell cancer, major clinical study, mucosa inflammation
العلاقة: Danson, S., Middleton, M. R., O'Byrne, Kenneth J., Clemons, M., Ranson, M., Hassan, J., Anderson, H., Burt, P. A., Fairve-Finn, C., Stout, R., Dowd, I., Ashcroft, L., Beresford, C., & Thatcher, N. (2003) Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma. Cancer, 98(3), pp. 542-553.; https://eprints.qut.edu.au/64965Test/; Faculty of Health; Institute of Health and Biomedical Innovation
-
8
المؤلفون: Aravantinos, Gerasimos, Fountzilas, George, Kosmidis, Paraskevas A., Dimopoulos, M. A., Stathopoulos, G. P., Pavlidis, Nicholas, Bafaloukos, Dimitrios, Papadimitriou, C., Karpathios, S., Georgoulias, V., Papakostas, P., Kalofonos, H. P., Grimani, E., Skarlos, Dimosthenis V.
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalofonos, H. P. [0000-0002-3286-778X]
المصدر: Annals of Oncology
مصطلحات موضوعية: Drug dose regimen, Oncology, Survival rate, medicine.medical_treatment, Ovarian Neoplasms/*drug therapy, Carboplatin, Phase 3 clinical trial, Antineoplastic Combined Chemotherapy Protocols, Cytoreductive surgery, Drug fatality, Prospective Studies, Treatment outcome, Disease free survival, Ovarian Neoplasms, Multicenter study, Clinical trial, Heart ventricle arrhythmia, Antineoplastic agent, Paclitaxel, Randomized controlled trial, Granulocyte colony stimulating factor, Infection, Cimetidine, Human, medicine.medical_specialty, Febrile neutropenia, Major clinical study, Article, Disease-Free Survival, Drug Administration Schedule, Ovarian cancer, Paclitaxel/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse, Humans, Aged, Cisplatin, Recombinant granulocyte colony stimulating factor, Minimal residual disease, Leukopenia, Myalgia, Pneumonia, medicine.disease, Survival Analysis, Cardiotoxicity, Regimen, chemistry, Dimetindene, Survival, Alternating cisplatin with carboplatin, Cancer staging, Promethazine, Ovarian neoplasms, Dexamethasone, chemistry.chemical_compound, Controlled clinical trial, Nausea and vomiting, Nephrotoxicity, Fatigue, Priority journal, Drug tolerability, Area under the curve, Gastrointestinal toxicity, Initial treatment, Anemia, Hematology, Arthralgia, Ondansetron, Statistical significance, Chemotherapy regimen, Female, effects/*therapeutic use, Drug hypersensitivity, medicine.drug, Adult, Neutropenia, Fever, Ovary cancer, Liver toxicity, Pain, Mucosa inflammation, Advanced cancer, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Chemotherapy, Prospective study, Drug administration, business.industry, Carboplatin/administration & dosage, Thrombocytopenia, Standardization, Drug efficacy, Cancer patient, Patient Compliance, Ovary tumor, business, Controlled study, Cisplatin/administration & dosage
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be8edba7f2dc19cd758534f35e2c79cTest
http://olympias.lib.uoi.gr/jspui/handle/123456789/19485Test -
9
المؤلفون: Ender Kurt, Guzin Gonullu, Murat Arslan, Ozkan Kanat, Osman Manavoglu, Mutlu Demiray, Turkkan Evrensel, Murat Kiyici
المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Medikal Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı., Kanat, Özkan, Evrensel, Türkkan, Manavoğlu, Osman, Demiray, Mutlu, Kurt, Ender, Gönüllü, Güzin, Kıyıcı, Murat, Arslan, Murat, AAJ-1027-2021, M-8060-2019
المصدر: Tumori. 89(4)
مصطلحات موضوعية: Male, Cancer Research, ECOG Performance Status, Gastroenterology, Second-line chemotherapy, 030218 nuclear medicine & medical imaging, Carboplatin, 0302 clinical medicine, Drug safety, Liver metastasis, Survival time, Combination chemotherapy, Anemia, General Medicine, Middle Aged, Clinical trial, Lung metastasis, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Disease Progression, Female, Fluorouracil, medicine.drug, Human, Diarrhea, Adult, medicine.medical_specialty, Neutropenia, Paclitaxel, Mitomycin, Clinical article, Irinotecan, Loperamide, Article, 03 medical and health sciences, Mucosa inflammation, Stomach Neoplasms, Internal medicine, Advanced cancer, medicine, Peritoneum metastasis, Humans, Stomach carcinoma, Ramucirumab, Rivoceranib, Line, Survival analysis, Aged, Lymph node metastasis, business.industry, medicine.disease, Monotherapy, Thrombocytopenia, Antineoplastic Agents, Phytogenic, Survival Analysis, Surgery, Regimen, Drug efficacy, Methotrexate, Doxorubicin, Camptothecin, Phase-II, Cisplatin, business, Gastric cancer, Progressive disease, Supportive care
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b6ef5b813b9cfb143106f84b52ba1cTest
https://pubmed.ncbi.nlm.nih.gov/14606644Test -
10
المؤلفون: Mehmet H. Koseoglu, Hulki Meltem Sönmez, Ekrem Muftuoglu, Gurhan Kadikoylu, Süleyman Demir, Orhan Ayyildiz, Zahit Bolaman
المصدر: Haematologia. 32(1)
مصطلحات موضوعية: Male, drug megadose, age distribution, diarrhea, leukemia remission, rash, Gastroenterology, etoposide, hydroxyurea, granulocyte colony stimulating factor, cause of death, flushing, cytarabine, dose response, Streptococcus infection, neurotoxicity, Antineoplastic Combined Chemotherapy Protocols, conjunctivitis, Blastic phase, fever, clinical article, liver dysfunction, adult, Remission Induction, article, Cytarabine, prednisolone, Combination chemotherapy, clinical trial, Hematology, Middle Aged, alpha interferon, female, Treatment Outcome, carboplatin, Vomiting, mucosa inflammation, Female, medicine.symptom, Chronic myelogenous leukemia, medicine.drug, blast cell crisis, Adult, medicine.medical_specialty, azacitidine, Leukemia, Myeloid, Chronic, Nausea, cladribine, Blastic Phase, vincristine, Methylprednisolone, mitoxantrone, bone marrow hypoplasia, meprednisone, chronic myeloid leukemia, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, pneumonia, Humans, controlled study, human, bacteremia, survival time, lung toxicity, Mitoxantrone, controlled clinical trial, business.industry, 5 aza 2' deoxycytidine, leukopenia, fludarabine, Philadelphia 1 chromosome, medicine.disease, Survival Analysis, Surgery, Regimen, febrile neutropenia, imatinib, High dose methylprednisolone, validation process, Blastic phase chronic myelogenous leukemia, nausea and vomiting, prognosis, business, Blast Crisis, drug tolerability
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f90932862c6640e3652355e3f72548f7Test
https://pubmed.ncbi.nlm.nih.gov/12243555Test